Harvard Apparatus Regenerative Technology Return on Tangible Equity 2013-2025 | HRGN
Current and historical return on tangible equity values for Harvard Apparatus Regenerative Technology (HRGN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Harvard Apparatus Regenerative Technology Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.01B | $0.00B | -311.11% |
| 2024-12-31 | $-0.01B | $0.00B | -400.00% |
| 2024-09-30 | $-0.01B | $0.00B | -533.33% |
| 2024-06-30 | $-0.01B | $0.00B | -640.00% |
| 2024-03-31 | $-0.01B | $0.00B | -400.00% |
| 2023-12-31 | $-0.01B | $0.00B | -500.00% |
| 2023-09-30 | $-0.01B | $0.00B | -1333.33% |
| 2023-06-30 | $-0.01B | $0.00B | 1800.00% |
| 2023-03-31 | $-0.01B | $0.00B | 400.00% |
| 2022-12-31 | $-0.01B | $0.00B | 218.18% |
| 2022-09-30 | $-0.01B | $0.00B | 363.64% |
| 2022-06-30 | $-0.01B | $0.00B | 571.43% |
| 2022-03-31 | $-0.01B | $-0.01B | 720.00% |
| 2021-12-31 | $-0.01B | $0.00B | 0.00% |
| 2021-09-30 | $0.00B | $0.00B | -300.00% |
| 2021-06-30 | $0.00B | $0.00B | -300.00% |
| 2021-03-31 | $0.00B | $0.00B | -533.33% |
| 2020-12-31 | $-0.01B | $0.00B | -500.00% |
| 2020-09-30 | $-0.01B | $0.00B | -600.00% |
| 2020-06-30 | $-0.01B | $0.00B | -933.33% |
| 2020-03-31 | $-0.01B | $0.00B | -640.00% |
| 2019-12-31 | $-0.01B | $0.00B | -640.00% |
| 2019-09-30 | $-0.01B | $0.00B | -533.33% |
| 2019-06-30 | $-0.01B | $0.00B | -355.56% |
| 2019-03-31 | $-0.01B | $0.00B | -266.67% |
| 2018-12-31 | $-0.01B | $0.00B | -228.57% |
| 2018-09-30 | $-0.01B | $0.00B | -186.67% |
| 2018-06-30 | $-0.01B | $0.01B | -290.91% |
| 2018-03-31 | $-0.01B | $0.00B | -571.43% |
| 2017-12-31 | $-0.01B | $0.00B | -800.00% |
| 2017-09-30 | $-0.01B | $0.00B | -1120.00% |
| 2017-06-30 | $-0.01B | $0.00B | -560.00% |
| 2017-03-31 | $-0.01B | $0.00B | -325.00% |
| 2016-12-31 | $-0.01B | $0.00B | -220.00% |
| 2016-09-30 | $-0.01B | $0.01B | -153.85% |
| 2016-06-30 | $-0.01B | $0.01B | -120.00% |
| 2016-03-31 | $-0.01B | $0.01B | -117.65% |
| 2015-12-31 | $-0.01B | $0.01B | -107.32% |
| 2015-09-30 | $-0.01B | $0.01B | -123.08% |
| 2015-06-30 | $-0.01B | $0.01B | -133.33% |
| 2015-03-31 | $-0.01B | $0.01B | -123.08% |
| 2014-12-31 | $-0.01B | $0.01B | -123.08% |
| 2014-09-30 | $-0.01B | $0.01B | -100.00% |
| 2014-06-30 | $-0.01B | $0.01B | -112.82% |
| 2014-03-31 | $-0.01B | $0.01B | -142.86% |
| 2013-12-31 | $-0.01B | $0.02B | -240.00% |
| 2013-06-30 | $-0.01B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.023B | $0.000B |
| Harvard Apparatus Regenerative Technology Inc. provide greater clarity and visibility for its regenerative technology and expanding strategy on rejuvenation. Harvard Apparatus Regenerative Technology Inc., formerly known as Biostage Inc., is based in HOLLISTON, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.115B | 27.47 |
| CVS Health (CVS) | United States | $75.901B | 9.43 |
| Elevance Health (ELV) | United States | $65.016B | 8.74 |
| Cencora (COR) | United States | $56.164B | 19.54 |
| DiDi Global (DIDIY) | China | $25.650B | 27.25 |
| Labcorp Holdings (LH) | United States | $21.906B | 17.29 |
| Natera (NTRA) | United States | $18.548B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.156B | 0.00 |
| ICON (ICLR) | Ireland | $14.957B | 14.39 |
| CochLear (CHEOY) | Australia | $13.609B | 0.00 |
| Solventum (SOLV) | United States | $12.725B | 13.47 |
| Medpace Holdings (MEDP) | United States | $12.583B | 33.30 |
| Revvity (RVTY) | United States | $11.135B | 19.32 |
| Viatris (VTRS) | United States | $10.786B | 3.71 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.074B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.765B | 17.17 |
| HealthEquity (HQY) | United States | $8.282B | 36.28 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.001B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.183B | 30.52 |
| Amplifon S.p.A (AMFPF) | Italy | $5.058B | 27.69 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.446B | 19.58 |
| Surgery Partners (SGRY) | United States | $2.862B | 37.22 |
| Organon (OGN) | United States | $2.636B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.619B | 60.38 |
| Concentras Parent (CON) | United States | $2.589B | 14.96 |
| Alignment Healthcare (ALHC) | United States | $2.331B | 0.00 |
| Progyny (PGNY) | United States | $1.957B | 43.08 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Premier (PINC) | United States | $1.749B | 13.27 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Ardent Health (ARDT) | United States | $1.532B | 6.53 |
| Teladoc Health (TDOC) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.192B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.799B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.740B | 6.93 |
| CareDx (CDNA) | United States | $0.708B | 11.06 |
| Embecta (EMBC) | United States | $0.628B | 4.23 |
| So-Young (SY) | China | $0.507B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.489B | 0.00 |
| Nutex Health (NUTX) | United States | $0.474B | 7.18 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| Omada Health (OMDA) | $0.468B | 0.00 | |
| LifeMD (LFMD) | United States | $0.464B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.456B | 10.27 |
| SBC Medicals (SBC) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.401B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.323B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.276B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |